Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Apr;7(4):280-282.
doi: 10.1016/S2468-1253(22)00040-1. Epub 2022 Feb 4.

Is the attenuated humoral response to COVID-19 vaccination in anti-TNF users relevant?

Tarun Chhibba  1 , Laura E Targownik  2
Affiliations
Comment

Is the attenuated humoral response to COVID-19 vaccination in anti-TNF users relevant?

Tarun Chhibba et al. Lancet Gastroenterol Hepatol. 2022 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

TC declares no competing interests. LET has received grants and consulting fees from AbbVie Canada, Pfizer Canada, Takeda Canada, Janssen Canada, Roche Canada, Merck Canada, Sandoz Canada, and Janssen Canada; consulting fees from Celltron Canada; and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or education events from Takeda Canada, Janssen Canada, and AbbVie Canada.

Comment on

References

    1. Kennedy NA, Goodhand JR, Bewshea C, et al. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut. 2021;70:865–875. - PubMed
    1. Alexander JL, Kennedy NA, Ibraheim H, et al. COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study. Lancet Gastroenterol Hepatol. 2020 doi: 10.1016/S2468-1253(22)00005-X. published online Feb 3. - DOI - PMC - PubMed
    1. Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27:1205–1211. - PubMed
    1. Earle KA, Ambrosino DM, Fiore-Gartland A, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021;39:4423–4428. - PMC - PubMed
    1. Khan N, Patel D, Xie D, Pernes T, Lewis J, Yang Y-X. Are patients with inflammatory bowel disease at an increased risk of developing SARS-CoV-2 than patients without inflammatory bowel disease? Results from a nationwide veterans' affairs cohort study. Am J Gastroenterol. 2021;116:808–810. - PubMed

Substances